findmyKOL

Tiffany Mayo, MD

Enriched profile

Associate Professor of Dermatology; Director, Dermatology Clinical Research Unit · University of Alabama at Birmingham (UAB)

ORCIDNPI
Region🇺🇸 Birmingham, AL · Southeast · United StatesSpecialtyDermatologyFocusAcne / Hidradenitis+1
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Tiffany Mayo is Associate Professor of Dermatology; Director, Dermatology Clinical Research Unit at University of Alabama at Birmingham (UAB). OpenAlex indexes 95 publications with 330 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Tiffany Mayo is Associate Professor of Dermatology at University of Alabama at Birmingham (UAB), Department of Dermatology. The public record shows 95 publications with 330 citations (h-index 11), centered on Acne / Hidradenitis, Atopic Dermatitis / Eczema. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 22 companies.

  • Most recent indexed publication: 2026 · American journal of clinical dermatology
  • Top research focus: Acne / Hidradenitis
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atopic Dermatitis / Eczema1 trialAcne / Hidradenitis1 trialHidradenitis Suppurativa1 trialLymphadenitis1 trial

Research focus

OpenAlex concept fingerprint
Acne / HidradenitisAtopic Dermatitis / Eczema

Drugs & molecules

across trials, industry payments and publications
Eucrisageneric · CrisaboroleClinical trialsIndustry payments4Publications1Tremfyageneric · GuselkumabClinical trialsIndustry payments36PublicationsDupixentgeneric · DupilumabClinical trialsIndustry payments16Publications

Works with

trial sponsors and companies reporting payments
Janssen Biotech, Inc.Clinical trialsIndustry payments35E.R. Squibb & Sons, L.L.C.Clinical trialsIndustry payments32Pfizer Inc.Clinical trialsIndustry payments31

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
95publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

330citations

Total citations across indexed works.

11h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    29.2%
    Azole Antifungal15.9%
    Ketoconazole100%
    Part D16 patients
    Lincosamide Antibacterial9.9%
    Clindamycin Phosphate100%
    Part D12 patients
  • Dermatology

    22.9%
    Interleukin-4 Receptor alpha Antagonist11.5%
    Dupixent Pen68%Dupixent Syringe32%
    Part D<11 patients
    Corticosteroid11.5%
    Triamcinolone Acetonide71%Halobetasol Propionate30%
    Part D<11 patients
  • Cancer & immunology

    16.1%
    TNF inhibitor8.6%
    Remicade64%Humira(Cf) Pen36%
    Part D<11 patients
    Kinase inhibitor4.2%
    Opzelura100%
    Part D<11 patients
5 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/tiffany-mayo-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/tiffany-mayo-ms-md-87749b80

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Tiffany-Mayo

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UABMedicine/videos/join-us-as-we-talk-live-with-tiffany-mayo-md-and-her-patient-anye-about-the-cool/2216965765002647

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Instagram

    instagram.com/p/DQZkSEaDgTR

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    2026.acrpnet.org/mayo-tiffany

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →2026.acrpnet.org
9 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    Baylor College of Medicine, Houston, TX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu
  • M.S. in Chemistry

    Tuskegee University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu
  • B.S. in Chemistry

    Tuskegee University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu
  • Internal Medicine internship

    McGaw Medical Center of Northwestern University, Chicago, IL

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu
  • Dermatology residency

    University of Alabama at Birmingham School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com

Editorial & leadership roles

journal and society appointments
  • Director

    Dermatology Clinical Research Unit, UAB

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Affiliated provider

    Birmingham VA Medical Center (per third-party physician directory; not independently confirmed on a second source)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Media & interviews

press, podcasts and appearances
3 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.